510(k) clearance K260431 for Synovis Life Technologies, Inc. (Baxter International Inc.). View source facts, labeled dates, and the original FDA record.
Synovis Life Technologies, Inc. (Baxter International Inc.)
FDA decision date
Nov 5, 2026
First observed by MedTech Watch
Nov 17, 2026
Latest observed content change
Nov 17, 2026
Decision stated in the source
Substantially Equivalent
Source facts
Decision
Substantially Equivalent
Received
2026-01-27
Specialty
Neurology
Decision code
SESE
Clearance type
Traditional
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.